Factors responsible for glucose intolerance in Japanese subjects with impaired fasting glucose

Hormone and Metabolic Research

Volumn 39, Issue 1, 2007, Pages 41-45

  Izuka, M ^a   Fukushima, M ^a   Taniguchi, A ^b   Nakai, Y ^c   Suzuki, H ^a   Kawakita, T ^d   Kawamata, S ^a   Kajimoto, O ^e   Tsuda, K ^f   Inagaki, N ^f   Murakami, M ^a   Seino, Y ^b  

^a FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b KANSAI DENRYOKU HOSPITAL   (Japan)

^c Karasumaoike Nakai Clinic   (Japan)

^d Kyoto Preventive Medical Center   (Japan)

^e Soiken Incorporation   (Japan)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

Impaired fasting glucose; Impaired glucose tolerance; Insulin secretion; Insulin sensitivity; Insulinogenic index

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; JAPAN; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ASIAN; BLOOD; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; MIDDLE AGED; SECRETION;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; FASTING; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MIDDLE AGED;

EID: 33947598932     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-957344     Document Type: Article

References (38)

1. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924
2. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980; 1: 1373-1376
3. Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C: Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 1999; 16: 212-218
4. Eguchi H, Kato T, Tominaga M: Significance of IGT and impaired fasting glucose on the risk of development of diabetes. The Funagata Diabetes Study. Diabetes (Japan) 1998; 41: A107-A109
5. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M: Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes 2004; 53: 1782-1789
6. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R: The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 2003; 52: 1475-1484
7. Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, Mykkanen L, Karter AJ, Hamman R, Saad MF: Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 1997; 46: 63-69
8. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, Tokuyama K: Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 1992; 41: 1540-1546
9. Fukushima M, Nakai Y, Taniguchi A, Imura H, Nagata I, Tokuyama K: Insulin sensitivity, insulin secretion, and glucose effectiveness in anorexia nervosa: a minimal model analysis. Metabolism 1993; 42: 1164-1168
10. Taniguchi A, Nakai Y, Doi K, Fukushima M, Nagata I, Kawamura H, Imura H, Suzuki M, Tokuyama K: Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis. Diabetes 1994; 43: 1211-1217
11. Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, Nakai Y, Matsuura T, Kuroe A, Yasuda K, Kurose T, Seino Y, Yamada Y: Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia. Diabetes Care 2003; 26: 1211-1215
12. Nishi Y, Fukushima M, Suzuki H, Mitsui R, Ueda N, Taniguchi A, Nakai Y, Kawakita T, Kurose T, Seino Y, Yamada Y: Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia. Diabetes Res Clin Pract 2005; 70: 46-52
13. Mitsui R, Fukushima M, Nishi Y, Ueda N, Suzuki H, Taniguchi A, Nakai Y, Kawakita T, Kurose T, Yamada Y, Inagaki N, Seino Y: Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men. Metabolism 2006; 55: 53-58
14. Report of the Expert Committee on the Diagnosis Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
16. Fukushima M, Taniguchi A, Sakai M, Doi K, Nagasaka S, Tanaka H, Tokuyama K, Nakai Y: Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis. Diabetes Care 1999; 22: 1911-1912
17. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, Yano Y, Adachi Y: Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001; 24: 362-365
18. Seltzer HS, Allen EW, Herron AL, Jr, Brennan MT: Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 1967; 46: 323-335
19. Seino Y, Ikeda M, Yawata M, Imura H: The insulinogenic index in secondary diabetes. Horm Metab Res 1975;107-115
20. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470
21. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance National Diabetes Data Group. Diabetes 1979; 28: 1039-1057
22. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553
23. Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, Nagasaka S, Doi K, Okumura T, Fukuda A, Kishimoto H, Fukuda T, Nakaishi S, Tokuyama K, Nakai Y: Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000; 23: 1766-1769
24. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2192
25. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS: Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 1997; 20: 1859-1862
26. Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarenga JC, Perez-Jauregui J, Guillen-Pineda LE, Rull JA: Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 1998; 21: 1886-1888
27. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Carstensen B, Tajima N, Iwamoto Y, Borch-Johnsen K, Borch-Jonsen K: The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype. Diabetes Res Clin Pract 2002; 55: 35-43
28. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995; 44: 1386-1391
29. Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L: Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state. Diabetologia 2000; 43: 1476-1483
30. Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC: Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 2000; 49: 975-980
31. Sekikawa A, Tominaga M, Takahashi K, Eguchi H, Igarashi M, Ohnuma H, Sugiyama K, Manaka H, Sasaki H, Fukuyama H et al Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care 1993; 16: 570-574
32. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Nomiyama K, Ohmori S, Yoshitake T, Shinkawa A et al The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study. Diabetologia 1994; 37: 897-904
33. Kosaka K, Kuzuya T, Yoshinaga H, Hagura R: A prospective study of health check examinees for the development of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity. Diabet Med 1996; 13: S120-S126
34. Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, Iwamoto Y, Tajima N: Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000; 43: 1470-1475
35. Seino Y, Kurahachi H, Goto Y, Taminato T, Ikeda M, Imura H: Comparative insulinogenic effects of glucose, arginine and glucagon in patients with diabetes mellitus, endocrine disorders and liver disease. Acta Diabetol Lat 1975; 12: 89-99
36. Taniguchi A, Fukushima M, Sakai M, Kataoka K, Nagata I, Doi K, Arakawa H, Nagasaka S, Tokuyama K, Nakai Y: The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism 2000; 49: 1001-1005
37. Kuroe A, Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura T, Suzuki H, Kurose T, Yasuda K, Yamada Y, Seino Y: Impaired beta-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance. Diabetes Res Clin Pract 2003; 59: 71-77
38. Thamer C, Haap M, Heller E, Joel L, Braun S, Tschritter O, Haring H, Fritsche A: Beta cell function, insulin resistance and plasma adiponectin concentrations are predictors for the change of postprandial glucose in non-diabetic subjects at risk for type 2 diabetes. Horm Metab Res 2006; 38: 178-182